Free tool
Drug Search
Every brand-name drug and biologic application (NDA or BLA) in Drugs@FDA: 5,899 in all. Generic (ANDA) applications are not listed; their reference drug is.
Last checked: Nov 20, 2026Drugs@FDA last updated: Nov 18, 2026Methods & limitations
6 matches for "Acrotech Biopharma"
Brand names that start with your search come first, then marketed and novel drugs.
| Drug | Sponsor | Application | First approved | Programs |
|---|---|---|---|---|
| Adquey Difamilast | Acrotech Biopharma | NDA219474 | Feb 12, 2026 | Novel |
| Folotyn Pralatrexate | Acrotech Biopharma | NDA022468 | Sep 24, 2009 | NovelAccelerated approvalPriority reviewOrphan |
| Beleodaq Belinostat | Acrotech Biopharma | NDA206256 | Jul 3, 2014 | NovelAccelerated approvalPriority reviewOrphan |
| Evomela Melphalan Hydrochloride | Acrotech Biopharma | NDA207155 | Mar 10, 2016 | Orphan |
| Khapzory Levoleucovorin | Acrotech Biopharma | NDA211226 | Oct 19, 2018 | Orphan |
| Fusilev Levoleucovorin Calcium | Acrotech Biopharma | NDA020140 | Mar 7, 2008 | OrphanDiscontinued |
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.